#sanofi — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #sanofi, aggregated by home.social.
-
Sanofi stock steadies as upgraded 2026 guidance follows strong Q2 momentum
Sanofi stock is showing a steady tone in the latest session after the Paris-based drugmaker reported stronger Q2…
#France #FR #Europe #EU #Sanofi #FR0000127771
https://www.europesays.com/france/67461/ -
Is Sanofi (ENXTPA:SAN) Reasonable After A 10% Three Year Slide?
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million…
#France #FR #Europe #EU #Sanofi #Sanofistock
https://www.europesays.com/france/67448/ -
Sanofi reprimanded for disparaging Pfizer’s RSV vaccine
A U.K. marketing watchdog has reprimanded Sanofi for using “a highly misleading interpretation of data” to make disparaging…
#France #FR #Europe #EU #Sanofi #Abrysvo #Beyfortus #FiercePharmaHomepage #marketing #Pfizer #pharma #PMCPA #RSV
https://www.europesays.com/france/67182/ -
Sanofi gets FDA untitled letter over Beyfortus promotional emails
The FDA has called out Sanofi’s promotion of respiratory syncytial virus (RSV) antibody Beyfortus in a new untitled…
#France #FR #Europe #EU #Sanofi #Beyfortus #FDA #FiercePharmaHomepage #marketing #OPDP #untitledletter
https://www.europesays.com/france/67163/ -
New CEO Garijo sketches out vision to redirect Sanofi’s fortunes
In her inaugural earnings call as the new CEO of Sanofi, Belén Garijo—until recently head honcho at Germany’s…
#France #FR #Europe #EU #Sanofi #BelénGarijo #Dupixent #Earnings #FiercePharmaHomepage #PaulHudson #pharma #pharmaCEO #pipeline #Womenbiopharmaexecutives
https://www.europesays.com/france/67148/ -
Sanofi asked to change Dupixent ads after Galderma challenge
Galderma Laboratories has landed a blow on Sanofi in its multi-case advertising row, driving the French drugmaker to change…
#France #FR #Europe #EU #Sanofi #DTCadvertising #Dupixent #FiercePharmaHomepage #Galderma #marketing #NationalAdvertisingDivision #pharma
https://www.europesays.com/france/67111/ -
Sanofi (ENXTPA:SAN) On TD Cowen Spotlight And The Case For A Higher Valuation
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply…
#France #FR #Europe #EU #Sanofi #Cowen #fairvalue #immunology #individualinvestors #rarediseases
https://www.europesays.com/france/67000/ -
Sanofi (ENXTPA:SAN) On TD Cowen Spotlight And The Case For A Higher Valuation
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply…
#France #FR #Europe #EU #Sanofi #Cowen #fairvalue #immunology #individualinvestors #rarediseases
https://www.europesays.com/france/66974/ -
Sanofi stock trades around mid-August lows as Q2 2026 earnings and guidance frame a cautious outlook
Sanofi (FR0000127771) stock is holding close to recent mid-August levels, with its US-listed shares last indicated at $43.72…
#France #FR #Europe #EU #Sanofi #FR0000127771
https://www.europesays.com/france/66342/ -
Sanofi to lay off 229 workers in Mass.
Sanofi, one of the state’s largest pharmaceutical employers, will lay off 229 workers, according to records the company…
#France #FR #Europe #EU #Sanofi #07powerplay
https://www.europesays.com/france/66332/ -
Sanofi to lay off 229 Blueprint Medicines staffers, close Cambridge offices following acquisition
In the first major workforce reduction disclosed under new CEO Belén Garijo, Sanofi is laying off 229 employees…
#France #FR #Europe #EU #Sanofi #BlueprintMedicines #Cambridge #FiercePharmaHomepage #jobcuts #layoffs #Massachusetts #pharma
https://www.europesays.com/france/66324/ -
Two Pompe Disease Treatments Are in Short Supply Weeks After Regulators Cited the Plant That Releases Them
Patients with Pompe disease in the United States and Europe are reporting delayed shipments of the enzyme infusions…
#France #FR #Europe #EU #Sanofi #enzymereplacementtherapy #Nexviazymesupply #Pompediseaseshortage #rarediseasedrugshortage #SanofiWaterfordplant
https://www.europesays.com/france/65371/ -
Sanofi: Information concerning the total number of voting rights and shares – July 2026
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of…
#France #FR #Europe #EU #Sanofi #2026 #and #concerning #information #July #number #of #Rights #shares #the #Total #voting
https://www.europesays.com/france/65348/ -
Sanofi stock steadies as Sanofi India trades at 3,261.20
Sanofi stock is anchored by Sanofi India at 3,261.20 rupees, up 0.39% as of August 14, 2026 at…
#France #FR #Europe #EU #Sanofi #FR0000127771
https://www.europesays.com/france/65016/ -
EC begins antitrust probe into Sanofi’s flu shot campaign
Nine months after raiding the offices of Sanofi in an unannounced inspection, the European Commission says it has started…
#France #FR #Europe #EU #Sanofi #Antitrust #CSL #EuropeanCommission #FiercePharmaHomepage #fluvaccine #fluad #Fluzone #marketing #marketinginvestigation #pharma #Seqirus
https://www.europesays.com/france/64783/ -
Sanofi unit in Ireland dinged by FDA on Altuviiio production
After a site visit by FDA inspectors yielded a Form 483 for Genzyme Ireland in early 2026, the…
#France #FR #Europe #EU #Sanofi #drugmanufacturing #facilities #FDAinspection #FDAwarningletter #FiercePharmaHomepage #genzyme #hemophilia #Ireland #Manufacturing #ManufacturingFacilities #pharma #qualitycontrol #U.S.FDA #WaterfordIreland
https://www.europesays.com/france/64769/ -
Resilient Sanofi stock edges higher as Q2 2026 growth and R&D reshuffle shape outlook
Sanofi (FR0000127771) stock is holding slightly above its recent levels as investors digest a mix of solid second…
#France #FR #Europe #EU #Sanofi #FR0000127771
https://www.europesays.com/france/64751/ -
Sanofi offers commitments to end EU flu shot antitrust probe
On the heels of a European Commission probe into whether Sanofi “disparaged” one of its flu vaccine rivals…
#France #FR #Europe #EU #Sanofi #Antitrust #CSL #drugmarketing #EuropeanCommission #EuropeanUnion #FiercePharmaHomepage #fluad #influenza #influenzavaccine #marketing #pharma
https://www.europesays.com/france/64737/ -
After FDA delay, Sanofi scores subcutaneous OBI nod for Sarclisa
Sanofi has scored FDA approval for its subcutaneous version of Sarclisa, giving the multiple myeloma treatment a potential…
#France #FR #Europe #EU #Sanofi #Darzalex #FiercePharmaHomepage #Johnson&Johnson #pharma #Sarclisa #subcutaneousdrugdelivery
https://www.europesays.com/france/64722/ -
Sanofi opens new chapters in Pfizer, Moderna mRNA patent litigation sagas
As Pfizer and Moderna have tied off certain threads in their separate webs of mRNA patent litigation, Sanofi…
#France #FR #Europe #EU #Sanofi #BioNTech #Comirnaty #covid-19 #drugdelivery #FiercePharmaHomepage #Lawsuits #lipidnanoparticledrugdeliverytech #Moderna #mRNA #patentlitigation #Pfizer #pharma #respiratorysyncytialvirus #Spikevax #vaccinedevelopment
https://www.europesays.com/france/64705/ -
Sanofi (ENXTPA:SAN) Wins Two Drug Approvals In Japan And The EU
Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million individual investors worldwide. Sanofi secured approval in Japan for Wayrilz (rilzabrutinib) to treat chronic immune thrombocytopenia. Cenrifki (tolebr…
#Japan #JP #JapanNews #immunethrombocytopenia #marketedproducts #news #Sanofi
https://www.alojapan.com/1502797/sanofi-enxtpasan-wins-two-drug-approvals-in-japan-and-the-eu/ -
https://www.alojapan.com/1502797/sanofi-enxtpasan-wins-two-drug-approvals-in-japan-and-the-eu/ Sanofi (ENXTPA:SAN) Wins Two Drug Approvals In Japan And The EU #ImmuneThrombocytopenia #Japan #JapanNews #MarketedProducts #news #Sanofi Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million individual investors worldwide. Sanofi secured approval in Japan for Wayrilz (rilzabrutinib) to treat chronic immune thrombocytopenia. Cenrifki (tolebrutinib) received EU approval for progressive mu
-
#news ⚡ Sanofi offen für moderate Erhöhung des Herstellerabschlags: Sanofi-Deutschlandchefin Heidrun Irschik-Hadjieff zeigt sich offen für eine moderate Erhöhung des Herstellerabschlags auf verschreibun... https://hubu.de/?p=331580 | #erhoehung #herstellerabschlags #sanofi #hubu
-
#news ⚡ Sanofi offen für moderate Erhöhung des Herstellerabschlags: Sanofi-Deutschlandchefin Heidrun Irschik-Hadjieff zeigt sich offen für eine moderate Erhöhung des Herstellerabschlags auf verschreibun... https://hubu.de/?p=331580 | #erhoehung #herstellerabschlags #sanofi #hubu
-
3 Healthcare Stocks That Pay You a Dividend While You Wait for a Recovery
Some investors have watched their healthcare stock holdings drop in value recently or over the years, yet they…
#NewsBeep #News #Healthcare #AU #Australia #Bristol #Bristol-MyersSquibb #Health #Medtronic #Sanofi #stockholdings #stockprice
https://www.newsbeep.com/au/631162/ -
#Airbus, #BNP, #Sanofi, #Zara… #MoniqueBarbut https://fr.wikipedia.org/wiki/Monique_Barbut ministre de l’ #écologie, est actionnaire de dizaines de grandes entreprises
Le #média "Vert" a examiné la déclaration de l’ex-patronne du #WWF #France à la Haute autorité pour la transparence de la vie publique et a découvert plus de 150 000 € d’actions détenues dans 27 grandes entreprises, dont certaines au lourd bilan écologique. https://vert.eco/articles/airbus-bnp-sanofi-zara-monique-barbut-ministre-de-lecologie-est-actionnaire-de-dizaines-de-grandes-entreprises
-
#Airbus, #BNP, #Sanofi, #Zara… #MoniqueBarbut https://fr.wikipedia.org/wiki/Monique_Barbut ministre de l’ #écologie, est actionnaire de dizaines de grandes entreprises
Le #média "Vert" a examiné la déclaration de l’ex-patronne du #WWF #France à la Haute autorité pour la transparence de la vie publique et a découvert plus de 150 000 € d’actions détenues dans 27 grandes entreprises, dont certaines au lourd bilan écologique. https://vert.eco/articles/airbus-bnp-sanofi-zara-monique-barbut-ministre-de-lecologie-est-actionnaire-de-dizaines-de-grandes-entreprises
-
#Airbus, #BNP, #Sanofi, #Zara… #MoniqueBarbut https://fr.wikipedia.org/wiki/Monique_Barbut ministre de l’ #écologie, est actionnaire de dizaines de grandes entreprises
Le #média "Vert" a examiné la déclaration de l’ex-patronne du #WWF #France à la Haute autorité pour la transparence de la vie publique et a découvert plus de 150 000 € d’actions détenues dans 27 grandes entreprises, dont certaines au lourd bilan écologique. https://vert.eco/articles/airbus-bnp-sanofi-zara-monique-barbut-ministre-de-lecologie-est-actionnaire-de-dizaines-de-grandes-entreprises
-
AI agenti mění fungování firem a organizací. A jak firmy v ČR využívají AI?
AzaNoviny - Techno
#ai #firmy #cesko #organizace #sanofi #osn
https://azanoviny.eu/2026/04/20/ai-agenti-meni-fungovani-firem-a-organizaci-a-jak-firmy-v-cr-vyuzivaji-ai/ -
AI agenti mění fungování firem a organizací. A jak firmy v ČR využívají AI?
AzaNoviny - Techno
#ai #firmy #cesko #organizace #sanofi #osn
https://azanoviny.eu/2026/04/20/ai-agenti-meni-fungovani-firem-a-organizaci-a-jak-firmy-v-cr-vyuzivaji-ai/ -
AI agenti mění fungování firem a organizací. A jak firmy v ČR využívají AI?
AzaNoviny - Techno
#ai #firmy #cesko #organizace #sanofi #osn
https://azanoviny.eu/2026/04/20/ai-agenti-meni-fungovani-firem-a-organizaci-a-jak-firmy-v-cr-vyuzivaji-ai/ -
AI agenti mění fungování firem a organizací. A jak firmy v ČR využívají AI?
AzaNoviny - Techno
#ai #firmy #cesko #organizace #sanofi #osn
https://azanoviny.eu/2026/04/20/ai-agenti-meni-fungovani-firem-a-organizaci-a-jak-firmy-v-cr-vyuzivaji-ai/ -
Global drug makers face pricing pressure as China targets affordable healthcare
Global pharmaceutical companies posted mixed earnings in China last year, with some firms warning that 2026 will be…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #astrazeneca #Beijing #China #donaldtrump #EliLilly #Gardasil #Health #keytruda #Merck #Mounjaro #Roche #Sanofi #Washington
https://www.newsbeep.com/us/571163/ -
Sanofi ousts CEO after stalled turnaround at vaccine giant
French drugmaker Sanofi ousted CEO Paul Hudson, ending a six-year tenure marked by a stalled drive to replace blockbuster drugs going off patent and rising pressure from US anti-vaccine policy and rhetoric. #sanofi #business #paulhudson #News #Reuters #Newsfeed Read the story here: 👉 Subscribe: Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on Twitter: Follow…
https://fllics.com/en/video/sanofi-ousts-ceo-after-stalled-turnaround-at-vaccine-giant/
-
Sanofi ousts CEO after stalled turnaround at vaccine giant
French drugmaker Sanofi ousted CEO Paul Hudson, ending a six-year tenure marked by a stalled drive to replace blockbuster drugs going off patent and rising pressure from US anti-vaccine policy and rhetoric. #sanofi #business #paulhudson #News #Reuters #Newsfeed Read the story here: 👉 Subscribe: Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on Twitter: Follow…
https://fllics.com/en/video/sanofi-ousts-ceo-after-stalled-turnaround-at-vaccine-giant/
-
Sanofi ousts CEO after stalled turnaround at vaccine giant
French drugmaker Sanofi ousted CEO Paul Hudson, ending a six-year tenure marked by a stalled drive to replace blockbuster drugs going off patent and rising pressure from US anti-vaccine policy and rhetoric. #sanofi #business #paulhudson #News #Reuters #Newsfeed Read the story here: 👉 Subscribe: Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on Twitter: Follow…
https://fllics.com/en/video/sanofi-ousts-ceo-after-stalled-turnaround-at-vaccine-giant/
-
Sanofi ousts CEO after stalled turnaround at vaccine giant
French drugmaker Sanofi ousted CEO Paul Hudson, ending a six-year tenure marked by a stalled drive to replace blockbuster drugs going off patent and rising pressure from US anti-vaccine policy and rhetoric. #sanofi #business #paulhudson #News #Reuters #Newsfeed Read the story here: 👉 Subscribe: Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on Twitter: Follow…
https://fllics.com/en/video/sanofi-ousts-ceo-after-stalled-turnaround-at-vaccine-giant/
-
Sanofi ousts CEO after stalled turnaround at vaccine giant
French drugmaker Sanofi ousted CEO Paul Hudson, ending a six-year tenure marked by a stalled drive to replace blockbuster drugs going off patent and rising pressure from US anti-vaccine policy and rhetoric. #sanofi #business #paulhudson #News #Reuters #Newsfeed Read the story here: 👉 Subscribe: Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on Twitter: Follow…
https://fllics.com/en/video/sanofi-ousts-ceo-after-stalled-turnaround-at-vaccine-giant-2/
-
Sanofi ousts CEO after stalled turnaround at vaccine giant
French drugmaker Sanofi ousted CEO Paul Hudson, ending a six-year tenure marked by a stalled drive to replace blockbuster drugs going off patent and rising pressure from US anti-vaccine policy and rhetoric. #sanofi #business #paulhudson #News #Reuters #Newsfeed Read the story here: 👉 Subscribe: Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on Twitter: Follow…
https://fllics.com/en/video/sanofi-ousts-ceo-after-stalled-turnaround-at-vaccine-giant-2/
-
Sanofi ousts CEO after stalled turnaround at vaccine giant
French drugmaker Sanofi ousted CEO Paul Hudson, ending a six-year tenure marked by a stalled drive to replace blockbuster drugs going off patent and rising pressure from US anti-vaccine policy and rhetoric. #sanofi #business #paulhudson #News #Reuters #Newsfeed Read the story here: 👉 Subscribe: Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on Twitter: Follow…
https://fllics.com/en/video/sanofi-ousts-ceo-after-stalled-turnaround-at-vaccine-giant-2/
-
Sanofi ousts CEO after stalled turnaround at vaccine giant
French drugmaker Sanofi ousted CEO Paul Hudson, ending a six-year tenure marked by a stalled drive to replace blockbuster drugs going off patent and rising pressure from US anti-vaccine policy and rhetoric. #sanofi #business #paulhudson #News #Reuters #Newsfeed Read the story here: 👉 Subscribe: Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on Twitter: Follow…
https://fllics.com/en/video/sanofi-ousts-ceo-after-stalled-turnaround-at-vaccine-giant-2/
-
Sanofi hợp tác cùng Long Châu khởi động dự án “Thu gom & Tái chế nhựa từ vỉ thuốc vì tương lai xanh”, tập trung thu gom, xử lý và tái chế nhựa để giảm ô nhiễm và xây dựng thói quen bền vững trong cộng đồng. 🌱♻️
#Sanofi #LongChau #Sustainability #GreenFuture #ThuGom #TaiChe #PlasticRecycling #bảnvững #tươnglaixanh
-
Johnson & Johnson announces deal to cut drug prices, new Pennsylvania manufacturing site | Berks Regional News
NEW BRUNSWICK, Nj. – Johnson & Johnson is the latest U.S. drugmaker to announce …
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #accesstomedicines #celltherapy #drugproductmanufacturingfacility #Health #joaquinduato #Johnson&Johnson #medicationcosts #MERCK&CO #Pennsylvania #Sanofi #TrumpAdministration #TrumpRx #trumprx.com
https://www.newsbeep.com/us/398424/ -
Sanofi kauft sich mit 2,56 Mrd. US-Dollar in die Zukunft der Medizin ein. Start-ups wie Earendil Labs wechseln von der bloßen Strukturvorhersage zur aktiven Konstruktion von Antikörpern mittels generativer KI. Parallel entwickelt das MIT KI-basierte Nanopartikel für die Krebsfrüherkennung. Die Ära des physischen Ausprobierens im Labor endet. Ist das der technologische Durchbruch oder ein gefährlicher Hype? #Sanofi #EarendilLabs #Pegasus
https://www.all-ai.de/news/news26/kuenstliche-antikoerper-sanofi -
Sanofi kauft sich mit 2,56 Mrd. US-Dollar in die Zukunft der Medizin ein. Start-ups wie Earendil Labs wechseln von der bloßen Strukturvorhersage zur aktiven Konstruktion von Antikörpern mittels generativer KI. Parallel entwickelt das MIT KI-basierte Nanopartikel für die Krebsfrüherkennung. Die Ära des physischen Ausprobierens im Labor endet. Ist das der technologische Durchbruch oder ein gefährlicher Hype? #Sanofi #EarendilLabs #Pegasus
https://www.all-ai.de/news/news26/kuenstliche-antikoerper-sanofi -
Prof. Scheibenbogen verkündet beim Fachgespräch zur Nationalen Dekade gegen Postinfektiöse Erkrankungen eine Medikamentenstudie der Charité gemeinsam mit dem Pharmaunternehmen #Sanofi und nennt diese Entwicklung einen "Meilenstein".
Zum Live-Stream: https://www.bundestag.de/mediathek/live
-
Prof. Scheibenbogen verkündet beim Fachgespräch zur Nationalen Dekade gegen Postinfektiöse Erkrankungen eine Medikamentenstudie der Charité gemeinsam mit dem Pharmaunternehmen #Sanofi und nennt diese Entwicklung einen "Meilenstein".
Zum Live-Stream: https://www.bundestag.de/mediathek/live
-
Prof. Scheibenbogen verkündet beim Fachgespräch zur Nationalen Dekade gegen Postinfektiöse Erkrankungen eine Medikamentenstudie der Charité gemeinsam mit dem Pharmaunternehmen #Sanofi und nennt diese Entwicklung einen "Meilenstein".
Zum Live-Stream: https://www.bundestag.de/mediathek/live
-
Prof. Scheibenbogen verkündet beim Fachgespräch zur Nationalen Dekade gegen Postinfektiöse Erkrankungen eine Medikamentenstudie der Charité gemeinsam mit dem Pharmaunternehmen #Sanofi und nennt diese Entwicklung einen "Meilenstein".
Zum Live-Stream: https://www.bundestag.de/mediathek/live
-
Impfmöglichkeit Booster Auffrischung 💉 #Sanofi #Novavax #Nuvaxovid #JN.1 #Biontech #Comirnaty #L.P.8.1 🏥 Reischmann Apotheke #Bahnstadt 📍Da-Vinci-Str. 7 69115 #Heidelberg #BaWü 📞 06221-24662 📧 [email protected] #COVID19 #CovidIsNotOver #TeamVorsicht #Impfung #impflp81 #nuvax25
